Terpos, E., E. Kastritis, S. Delimpasi, K. Papathanasiou, V. Labropoulou, N. Kanellias, I.N. Stathopoulos, M. Migkou, E. Solia, F. Theodorakakou, E.E. Papaiakovou, M. Kotsopoulou, E. Katodritou, M. Gavriatopoulou, and M.A. Dimopoulos. 2026. “P13 | ISATUXIMAB WITH BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE FOLLOWED BY ISATUXIMAB AND LENALIDOMIDE MAINTENANCE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH SEVERE RENAL IMPAIRMENT: FINAL ANALYSIS OF A PHASE 2 STUDY BY GREEK MYELOMA STUDY GROUP”. Haematologica 111 (s2). Pavia, Italy. https://doi.org/10.3324/haematol.2026.s2.14108.